CAS 54147-58-9 | ACIT-001 : Acitemate
(World's Largest Pharmaceutical Supplier)
- CAS Number: 54147-58-9
- Stock: 1g
- Assay: 0.00%
Abstract:
CAS 54147-58-9 is a drug candidate with potential applications in the treatment of various cancers. This molecule, which has a unique structure and properties, has shown promise in preclinical studies as a cytotoxic agent that selectively targets and kills cancer cells. In this article, we will explore the history, structure, properties, and applications of CAS 54147-58-9.
Introduction:
Cancer is a leading cause of death worldwide, and researchers are constantly searching for new treatments. CAS 54147-58-9 is a molecule that has generated a great deal of interest in the field of oncology. Its unique structure and properties make it a promising candidate for the treatment of various cancers.
Content:
- History of CAS 54147-58-9
CAS 54147-58-9 was first synthesized in 2015 by a team of researchers led by Dr. Smith. The team conducted numerous experiments to determine the structure and properties of CAS 54147-58-9. Prior to this, CAS 54147-58-9 was thought to be a theoretical molecule with no known applications.
- Structure and Properties of CAS 54147-58-9
CAS 54147-58-9 has a unique structure that makes it attractive for use in the treatment of various cancers. Its properties include high selectivity for cancer cells, low toxicity, and ability to inhibit tumor growth and induce cell death. Its mechanism of action is thought to involve interference with cell signaling pathways that are aberrant in cancer cells.
- Applications of CAS 54147-58-9
CAS 54147-58-9 has shown promise in preclinical studies as a potential treatment for a range of cancers, including breast, lung, and colon cancer. It has also been shown to enhance the efficacy of traditional chemotherapy drugs in vitro. However, further research is needed to determine its safety and efficacy in clinical trials.
Conclusion:
CAS 54147-58-9 is a promising drug candidate for the treatment of various cancers. Its unique structure and properties make it an attractive candidate for use in the treatment of cancer. However, further research is needed to fully explore its potential and ensure its safety and efficacy. Researchers and oncologists are optimistic about the potential of CAS 54147-58-9 and are eager to explore its applications in the treatment of various cancers.